EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas

Halin Bareke iD, Adrián Ibáñez-Navarro, Pilar Guerra-García iD, Carlos González Pérez, Pedro Rubio-Aparicio, Diego Plaza López de Sabando, Ana Sastre-Urgelles, Eduardo José Ortiz-Cruz, Antonio Pérez-Martínez iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098324 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Halin Bareke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Group in Pediatric Oncology, Haematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, I…. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Osteosarcoma, Neoplasms, Sarcoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The CRIS Cancer Foundation, Fundación Mari Paz Jiménez Casado and Fundación La Sonrisa de Alex, CRIS Cancer Foundation, Fundación Mari Paz Jiménez Casado.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant bone tumors are aggressive tumors, with a high tendency to metastasize, that are observed most frequently in adolescents during rapid growth spurts. Pediatric patients with malignant bone sarcomas, Ewing sarcoma and osteosarcoma, who present with progressive disease have dire survival rates despite aggressive therapy. These therapies can have long-term effects on bone growth, such as decreased bone mineral density and reduced longitudinal growth. New therapeutic approaches are therefore urgently needed for targeting pediatric malignant bone tumors. Harnessing the power of the immune system against cancer has improved the survival rates dramatically in certain cancer types. Natural killer (NK) cells are a heterogeneous group of innate effector cells that possess numerous antitumor effects, such as cytolysis and cytokine production. Pediatric sarcoma cells have been shown to be especially susceptible to NK-cell-mediated killing. NK-cell adoptive therapy confers numerous advantages over T-cell adoptive therapy, including a good safety profile and a lack of major histocompatibility complex restriction. NK-cell immunotherapy has the potential to be a new therapy for pediatric malignant bone tumors. In this manuscript, we review the general characteristics of osteosarcoma and Ewing sarcoma, discuss the long-term effects of sarcoma treatment on bones, and the barriers to effective immunotherapy in bone sarcomas. We then present the laboratory and clinical studies on NK-cell immunotherapy for pediatric malignant bone tumors. We discuss the various donor sources and NK-cell types, the engineering of NK cells and combinatorial treatment approaches that are being studied to overcome the current challenges in adoptive NK-cell therapy, while suggesting approaches for future studies on NK-cell immunotherapy in pediatric bone tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingOsteosarcomaNeoplasmsSarcomaBone NeoplasmsAdolescentHumansChildImmunotherapy, AdoptiveKiller Cells, NaturalImmunotherapyCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

Ewing sarcomaNK cellsadoptive cell therapyimmune evasionimmunotherapyosteosarcomapediatric bone sarcomatumor microenvironment

Autor:innen und Institutionen

  • Translational Research Group in Pediatric Oncology, Haematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
  • Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
  • Department of Orthopedic Surgery and Traumatology, La Paz University Hospital, 28046 Madrid, Spain.
  • School of Medicine, Autonomous University of Madrid, 28046 Madrid, Spain.

ORCID-Profile: Halin Bareke, Pilar Guerra-García, Antonio Pérez-Martínez

Förderung

  • The CRIS Cancer Foundation, Fundación Mari Paz Jiménez Casado and Fundación La Sonrisa de Alex
  • CRIS Cancer Foundation
  • Fundación Mari Paz Jiménez Casado
  • Fundación La Sonrisa de Alex

Zitieren

APA

Bareke, H., Ibáñez-Navarro, A., Guerra-García, P., González Pérez, C., Rubio-Aparicio, P., Plaza López de Sabando, D., Sastre-Urgelles, A., Ortiz-Cruz, E. J., & Pérez-Martínez, A. (2023). Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098324

Vancouver

Bareke H, Ibáñez-Navarro A, Guerra-García P, González Pérez C, Rubio-Aparicio P, Plaza López de Sabando D, et al. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098324

BibTeX
@article{Bareke2023,
  author = {Bareke, Halin and Ibáñez-Navarro, Adrián and Guerra-García, Pilar and González Pérez, Carlos and Rubio-Aparicio, Pedro and Plaza López de Sabando, Diego and Sastre-Urgelles, Ana and Ortiz-Cruz, Eduardo José and Pérez-Martínez, Antonio},
  title = {Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098324}
}
Kostenlos starten →